CompaniesExicure

Exicure

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

73

By Phase

PHASE1/PHASE2: 1PHASE1: 1

By Status

TERMINATED: 1COMPLETED: 1

Recent Trials

NCT03684785Lead Sponsor
Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors
PHASE1/PHASE2Terminated
57 participants
Started: Dec 13, 2018 · Completed: Mar 30, 2022
NCT03086278Lead Sponsor
A Study of AST-008 in Healthy Subjects
PHASE1Completed
16 participants
Started: Oct 20, 2017 · Completed: Aug 16, 2018